Open Access
Subscription or Fee Access
Effects of multiglutine during cancer chemotherapy on gastrointestinal toxicity and liver dysfunction
Abstract
Introduction: Cancer chemotherapy causes severe side effects in almost patients by inhibiting various systems including the hematopoietic, gastrointestinal and nervous systems. Recently, glutamine has been considered to improve the side effects of cancer chemotherapy. Calcium and magnesium also have positive effects in cancer patients. In this study, we evaluated effects of multiglutine, which consists of glutamic acid and metal ions such as calcium, magnesium, on gastrointestinal toxicity and liver dysfunction during cancer chemotherapy.
Patients and methods: Sixty-three patients who had been diagnosed as malignant lymphoma were divided into the multiglutine group (32 patients) and the control group (31 patients). The patients in multiglutine group received 15 g/d of multiglutine from 1 day prior to the start of chemotherapy until 6 day after chemotherapy.
Results : The group treated with multiglutine had vomiting grade 1-2 12.5%, nausea 18.8%, stomatitis grade 1-2 3.1%, diarrhea grade 1-2 6.3%, and liver dysfunction grade 1-2 3.1%, whereas the control group had vomiting grade 1-2 22.6%, grade 3-4 16.1%, nausea 45.2%, stomatitis grade 1-2 19.4%, diarrhea grade 1-2 25.8%, and liver dysfunction grade 1-2 9.7%, grade 3-4 6.5%.
Conclusions: Multiglutine can significantly reduce gastrointestinal toxicity and liver dysfunction during cancer chemotherapy.References
Alex J. Bott, Sara Maimouni et al (2019) The Pleiotropic Effects of Glutamine Metabolism in Cancer. Cancers 1-16
Alfonso Vidal-Casariego, Alicia Calleja-Fernández et al (2015) Effects of oral glutamine during abdominal radiotherapy on chronic radiation enteritis: A randomized controlled trial. Nutrition 200-204
Andrea M. Stringer, Noor Al-Dasooqi et al (2013) Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases. Support Care Cancer 1843-1852
Andres F Carrion et al (2010) Severe colitis associated with docetaxel use:A report of four cases. World Journal of Gastrointestinal Oncology 390-394
Carl,-W; Havens,-J et al (2000) The cancer patient with severe mucositis. Curr-Rev-Pain. 4(3): 197-202
Cerchietti, Leandro C.A, Navigante, Alfredo H et al (2006) Double-blinded, placebo-controlled trial on intravenous l-alanyl-l-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer. International Journal of Radiation Oncology Biology Physics 1330-1337
Charles C. Horn, Eric J. Richardson, et al (2004) Differential effects on gastrointestinal and hepatic vagal afferent fibers in the rat by the anti-cancer agent cisplatin. Autonomic Neuroscience s 1–2: 74-81
Eda Kucuktulu, Ali Guner, Izzettin Kahraman et al (2013) The protective effects of glutamine on radiation-induced diarrhea. Support Care Cancer 21:1071–1075
Emilia Peleva, Nader Emami, et al (2014) Incidence of platinum-induced ototoxicity in pediatric patients in Quebec. Pediatric Blood Cancer 11:2012-2017
Faaiza Shahid, Zeba Farooqui, Farah Khan et al (2018) Cisplatin-induced gastrointestinal toxicity: An update on possible mechanisms and on available gastroprotective strategies. European Journal of Pharmacology 49-57
Hannah R. Wardill et al (2012) Chemotherapy-induced gut toxicity: are alterations to intestinal tight junctions pivotal? Cancer Chemotherapy and Pharmacology 627-635
Hirokazu Takechi, Kazuaki Mawatari, Nagakatsu Harada et al (2014) Glutamine protects the small intestinal mucosa in anticancer drug-induced rat enteritis model. J. Med. Invest. 61: 59-64
Kaya E, Gur ES, Özguc H et al (1999) L-glutamine enemas attenuate mucosal injury in experimental colitis. Dis Colon Rectum 42:1209–1215
L. Kriazhev (2009) Calcium channel as a potential anticancer agent. Medical Hypotheses 73: 655–656
Peter M. Anderson 1,* and Rajesh V. Lalla 2 et al (2020) Glutamine for Amelioration of Radiation and Chemotherapy Associated Mucositis during Cancer Therapy. Nutrients 1-15
R. Berrueco, Alonso-Saladrigues et al (2015) Outcome and toxicities associated to chemotherapy in children with acute lymphoblastic leukemia and Gilbert syndrome. Usefulness of UGT1A1 mutational screening. Pediatric Blood Cancer 7:1195-1201
Satyajit Dutta, Supratim Ray, K. Nagarajan et al (2013) Glutamic acid as anticancer agent: An overview. Saudi Pharmaceutical Journal 21, 337–343
Scheppach W, Dusel G, Kuhn T et al (1996) Effect of L-glutamine and n-butyrate on the restitution of rat colonic mucosa after acid induced injury. Gut 38:878–885
Scott M. Bradfield, Eric Sandler et al (2015) Glutamic acid not beneficial for the prevention of vincristine neurotoxicity in children with cancer. Pediatric Blood Cancer 6:1004-1010
Sherry Wolf, Debra Barton et al (2008) Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies. EUROPEAN JOURNAL OF CANCER 44: 1507–1515
Skubitz-KM, Anderson-PM et al (1996) Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study. J-Lab-Clin-Med. 127(2):
Suyoun Chung, Siew-Kee Low et al (2013) A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients. Breast Cancer Research 15:1-10
Tremel H, Kienle B, Weilemann LS et al (1994) Glutamine dipeptide-supplemented parenteral nutrition maintains intestinal function in the critically ill. Gastroenterology 107:1595–1601
Van der Julst RRWJ, Van Krell BK, Meyenfeldt V et al (1993) Glutamine and the preservation of gut integrity. Lancet 334:1363
Wilmore DW et al (1997) Metabolic support of the gastrointestinal tract: Potential gut protection during intensive cytotoxic therapy. Cancer 79(9):1794-1803
Wilmore DW, Shabert JK (1998) Role of glutamine in immunologic responses. Nutrition 14:618–626
Yuk-Wah Tsang, Kwan-Hwa Chi et al (2007) Chemotherapy-induced immunosuppression is restored by a fermented soybean extract: a proof of concept clinical trial. Nutrition Research 11:679-684
DOI: https://doi.org/10.37591/rrjom.v13i3.3198
Refbacks
- There are currently no refbacks.
Copyright (c) 2024 Research & Reviews: Journal of Medicine
This Journal archive has been shifted to: https://journals.stmjournals.com/archive/rrjom/